Prof. Dr. Hans-Christoph Becker from Stanford University, a long-standing user of mint Lesion™, shares his experience of using the software in this brief interview. He talks about the reaction he received when sharing the mint report for the first time, how patients benefit from the longitudinal overview of disease, and his plans to use the structured data for AI research.
Potential of longitudinal data from single site and multi-center clinical trials for AI-research
Related Resources
Related Resources
Mint-Data for Personalized Medicine at Cancer Center in Tübingen/Germany
Compiling structured real-world-data from different medical disciplines, such as molecular genetics, laboratory medicine, pathology or radiology, to…
Number of Clinical Trials in Oncology has increased strongly during the last 10 years
Cancer cases and cancer related deaths continue to increase globally. While new cancer therapies are being identified offering new options for…
New mint Lesion 3.4 Software presented at RSNA 2017
With mint Lesion 3.4, reproducible assessment and structured reporting of significant image observations are easier than ever. Numerous improvements…